ArticleJournal of hepatology2022

Erratum to 'Ribonuclease 7-driven activation of ROS1 is a potential therapeutic target in hepatocellular carcinoma' [J Hepatol 2021 (907-918)].

Chunxiao Liu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.